EP 1370250 A2 20031217 - FLT-1 LIGANDS AND THEIR USES IN THE TREATMENT OF DISEASES REGULATABLE BY ANGIOGENESIS
Title (en)
FLT-1 LIGANDS AND THEIR USES IN THE TREATMENT OF DISEASES REGULATABLE BY ANGIOGENESIS
Title (de)
FLT-1 LIGANDEN SOWIE DEREN VERWENDUNG ZUR BEHANDLUNG VON DURCH ANGIOGENESE REGULIERBAREN ERKRANKUNGEN
Title (fr)
LIGANDS FLT-1 ET UTILISATIONS DE CEUX-CI DANS LE TRAITEMENT DES MALADIES REGLABLE PAR L'ANGIOGENESIS
Publication
Application
Priority
- US 0208862 W 20020321
- US 27815601 P 20010323
Abstract (en)
[origin: WO02076438A2] This invention is a method of treatment and prophylaxis diseases regulatable by angiogenesis, including novel pharmaceutical compositions and compounds, useful in the methods for the prophylaxis and treatment of diseases, as well as intermediates and processes useful for the preparation of the compounds of the invention as claimed.
[origin: WO02076438A2] This invention is a method of treatment and prophylaxis of diseases regulatable by angiogenesis, including novel FLT-1 ligands and pharmaceutical compositions containing them, useful in the methods for the treatment and prophylaxis of these diseases, as well as intermediates and processes useful for the preparation of the compounds of the invention as claimed.
IPC 1-7
A61K 31/00; A61K 31/4245; A61K 31/44; A61K 31/4439; A61K 31/444; A61K 31/506; A61K 31/53; C07D 403/14; A61P 9/00; A61P 9/10; A61P 35/00; A61P 27/02; A61P 19/02
IPC 8 full level
A61K 31/4245 (2006.01); A61K 31/4439 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61K 31/53 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 17/00 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 43/00 (2006.01); C07D 239/26 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/10 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01)
CPC (source: EP)
A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/06 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12); C07D 239/26 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/10 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/14 (2013.01)
Citation (search report)
See references of WO 02076438A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02076438 A2 20021003; WO 02076438 A3 20030501; AU 2002247402 A1 20021008; EP 1370250 A2 20031217; JP 2004525139 A 20040819
DOCDB simple family (application)
US 0208862 W 20020321; AU 2002247402 A 20020321; EP 02715187 A 20020321; JP 2002574954 A 20020321